Richard Champlin

Department of Hematology, European Society for Blood and Marrow Transplantation (EBMT) Paris Study Office/Centros de Referência em Saúde do Trabalhador, Hôpital Saint Antoine, INSERM, Paris, France.

View Article and Find Full Text PDF

May 2020

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.

Blood Adv 2020 04;4(7):1296-1306

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF

April 2020

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.

Blood Adv 2020 03;4(6):1038-1050

Department of Lymphoma and Myeloma.

View Article and Find Full Text PDF

March 2020

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.

Authors:

Abraham S Kanate Navneet S Majhail Bipin N Savani Christopher Bredeson Richard E Champlin Stephen Crawford Sergio A Giralt Charles F LeMaistre David I Marks James L Omel Paul J Orchard Jeanne Palmer Wael Saber Paul A Veys Paul A Carpenter Mehdi Hamadani

Biol Blood Marrow Transplant 2020 07 9;26(7):1247-1256. Epub 2020 Mar 9.

BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.

View Article and Find Full Text PDF

July 2020

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.

Cancer 2020 05 3;126(10):2193-2205. Epub 2020 Mar 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

May 2020

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.

Authors:

Rima M Saliba Lauren Veltri Gabriela Rondon Julianne Chen Gheath Al-Atrash Amin Alousi Charles Martinez LaJerald Augustine Chitra M Hosing Betul Oran Katayoun Rezvani Elisabeth J Shpall Partow Kebriaei Issa F Khouri Uday Popat Richard E Champlin Stefan O Ciurea

Haematologica 2020 Feb 27;106(1):269-274. Epub 2020 Feb 27.

The University of Texas MD Anderson Cancer Center, Rochester, NY.

View Article and Find Full Text PDF

February 2020

Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.

Authors:

Fevzi F Yalniz Keyur P Patel Qaiser Bashir David Marin Sairah Ahmed Amin M Alousi Julianne Chen Stefan O Ciurea Katy Rezvani Uday R Popat Elizabeth J Shpall Richard E Champlin Betül Oran

Cancer 2020 05 26;126(10):2183-2192. Epub 2020 Feb 26.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

May 2020

Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.

Authors:

Ankur Varma Gabriela Rondon Samer A Srour Julianne Chen Celina Ledesma Richard E Champlin Stefan O Ciurea Rima M Saliba

Biol Blood Marrow Transplant 2020 05 9;26(5):1013-1020. Epub 2020 Feb 9.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

May 2020

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.

N Engl J Med 2020 02;382(6):545-553

From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston.

View Article and Find Full Text PDF

February 2020

Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic Malignancies.

Authors:

Stefan O Ciurea Piyanuch Kongtim Omar Hasan Jorge M Ramos Perez Janet Torres Gabriela Rondon Richard E Champlin

Clin Cancer Res 2020 05 4;26(10):2404-2410. Epub 2020 Feb 4.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

May 2020

Is unrelated donor or haploidentical hematopoietic transplantation preferred for patients with acute myeloid leukemia in remission?

Authors:

Richard Champlin

Haematologica 2020 31;105(2):252-254. Epub 2020 Jan 31.

University of Texas, MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

July 2020

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.

Biol Blood Marrow Transplant 2020 04 24;26(4):665-671. Epub 2019 Dec 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

April 2020

Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.

Authors:

Ehab Atallah Brent Logan Min Chen Corey Cutler Joachim Deeg Meagan Jacoby Richard Champlin Taiga Nishihori Dennis Confer James Gajewski Stephanie Farnia Peter Greenberg Erica Warlick Daniel Weisdorf Wael Saber Mary M Horowitz J Douglas Rizzo

JAMA Oncol 2020 04;6(4):486-493

Center for International Bone Marrow Transplant Research, Medical College of Wisconsin, Milwaukee.

View Article and Find Full Text PDF

April 2020

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Authors:

Stefan O Ciurea Piyanuch Kongtim Ankur Varma Gabriela Rondon Julianne Chen Samer Srour Qaiser Bashir Amin Alousi Rohtesh Mehta Betul Oran Uday Popat Chitra Hosing Amanda Olson Naval Daver Marina Konopleva Richard E Champlin

Blood 2020 02;135(6):449-452

Department of Stem Cell Transplantation and Cellular Therapy and.

View Article and Find Full Text PDF

February 2020

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation.

Blood Adv 2019 12;3(23):4117-4130

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF

December 2019

Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation.

Authors:

David M Cordas Dos Santos Rima M Saliba Romil Patel Qaiser Bashir Neeraj Saini Chitra Hosing Partow Kebriaei Issa F Khouri Yago Nieto Uday Popat Haris Ahmed Hans C Lee Elisabet E Manasanch Krina K Patel Sheeba K Thomas Donna M Weber Robert Z Orlowski Richard E Champlin Muzaffar H Qazilbash

Biol Blood Marrow Transplant 2020 06 29;26(6):1077-1083. Epub 2019 Nov 29.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

June 2020

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.

Am J Hematol 2019 12 21;94(12):1382-1387. Epub 2019 Oct 21.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

December 2019

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

Blood Adv 2019 10;3(19):2836-2844

Center for International Blood and Marrow Transplant Research, and.

View Article and Find Full Text PDF

October 2019

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.

Authors:

Piyanuch Kongtim Omar Hasan Jorge Miguel Ramos Perez Ankur Varma Sa A Wang Keyur P Patel Julianne Chen Gabriela Rondon Samer Srour Qaiser Bashir Muzaffar Qazilbash Rohtesh Mehta Elizabeth J Shpall Amin Alousi Issa Khouri Partow Kebriaei Uday Popat Richard R Champlin Stefan O Ciurea

Biol Blood Marrow Transplant 2020 01 10;26(1):197-203. Epub 2019 Sep 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

January 2020

Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis.

Clin Cancer Res 2019 11 3;25(22):6781-6787. Epub 2019 Sep 3.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

November 2019

Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.

Authors:

Lynn El Haddad Shashank S Ghantoji Anne K Park Marjorie V Batista Jonathan Schelfhout Jack Hachem Yadira Lobo Ying Jiang Gabriela Rondon Richard Champlin Roy F Chemaly

J Med Virol 2020 01 3;92(1):86-95. Epub 2019 Sep 3.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

January 2020

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation.

Authors:

Samer A Srour Amanda Olson Stefan O Ciurea Parth Desai Qaiser Bashir Betul Oran Prithviraj Bose Rohtesh Mehta Keyur P Patel Naveen Pemmaraju Naval Daver Srdan Verstovsek Richard E Champlin Uday R Popat

Haematologica 2019 Jul 11. Epub 2019 Jul 11.

MD Anderson Cancer Center;

View Article and Find Full Text PDF

July 2019

Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years.

Authors:

Qaiser Bashir Kamal Chamoun Denái R Milton Maliha Khan Sairah Ahmed Rohtesh Mehta Uday R Popat Partow Kebriaei Yago Nieto Betul Oran Stefan O Ciurea Chitra Hosing Isa Khouri Krina Patel Elisabet E Manasanch Hans C Lee Robert Z Orlowski Richard E Champlin Muzaffar H Qazilbash

Leuk Lymphoma 2019 12 8;60(14):3536-3543. Epub 2019 Jul 8.

Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

December 2019

Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.

Authors:

Neeraj Y Saini Romil D Patel Ankur Varma Qaiser Bashir Ruby Delgado Gabriela Rondon Akash Mukherjee Uday Popat Chitra Hosing Yago Nieto Partow Kebriaei Donna M Weber Sheeba K Thomas Hans C Lee Elisabet E Manasanch Robert Z Orlowski Richard E Champlin Muzaffar H Qazilbash Krina K Patel

Ann Hematol 2019 Sep 26;98(9):2233-2235. Epub 2019 Jun 26.

Department of Lymphoma and Myeloma, MD Anderson Cancer, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

September 2019

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.

Authors:

Koen van Besien Andrew Artz Richard E Champlin Danielle Guarneri Michael R Bishop Julianne Chen Usama Gergis Tsiporah Shore Hongtao Liu Gabriela Rondon Sebastian A Mayer Samer A Srour Wendy Stock Stefan O Ciurea

Blood Adv 2019 06;3(12):1858-1867

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF

June 2019

Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.

Authors:

Zhihong Zeng Wenbin Liu Christopher B Benton Sergej Konoplev Hongbo Lu Rui-Yu Wang Julianne Chen Elizabeth Shpall Keith A Baggerly Richard Champlin Marina Konopleva

Acta Haematol 2019 21;142(3):176-184. Epub 2019 May 21.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA,

View Article and Find Full Text PDF

February 2020

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial.

Haematologica 2019 12 4;104(12):e555-e557. Epub 2019 Apr 4.

Department of Stem Cell Transplantation and Cellular Therapy

View Article and Find Full Text PDF

December 2019

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.

Lancet Haematol 2019 May 22;6(5):e266-e275. Epub 2019 Mar 22.

Department of Stem Cell Transplantation & Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.

View Article and Find Full Text PDF

May 2019

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.

Authors:

Stefan O Ciurea Panupong Hansrivijit Ana M Ciurea Sharon Hymes Julianne Chen Gabriela Rondon Chitra Hosing Uday Popat Richard E Champlin

Am J Hematol 2019 06 3;94(6):E176-E180. Epub 2019 Apr 3.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

June 2019

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.

Authors:

Kamal Chamoun Denái R Milton Celina Ledesma Ken H Young Elias J Jabbour Gheath Alatrash Paolo Anderlini Qaiser Bashir Stefan O Ciurea David Marin Jeffrey J Molldrem Amanda L Olson Betul Oran Uday R Popat Gabriela Rondon Richard E Champlin Alison M Gulbis Issa F Khouri

Biol Blood Marrow Transplant 2019 07 1;25(7):1347-1354. Epub 2019 Mar 1.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

July 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.

Biol Blood Marrow Transplant 2019 07 11;25(7):1340-1346. Epub 2019 Feb 11.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

July 2019

Hematologic malignancies and Li-Fraumeni syndrome.

Authors:

Mahesh Swaminathan Sarah A Bannon Mark Routbort Kiran Naqvi Tapan M Kadia Koichi Takahashi Yesid Alvarado Farhad Ravandi-Kashani Keyur P Patel Richard Champlin Hagop Kantarjian Louise Strong Courtney D DiNardo

Cold Spring Harb Mol Case Stud 2019 02 1;5(1). Epub 2019 Feb 1.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.

View Article and Find Full Text PDF

February 2019

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.

Authors:

Armin Ghobadi Denái R Milton Lohith Gowda Gabriela Rondon Roy F Chemaly Amir Hamdi Amin Alousi Aimaz Afrough Betul Oran Stefan Ciurea Partow Kebriaei Uday R Popat Muzaffar H Qazilbash Elizabeth J Shpall Richard E Champlin Qaiser Bashir

Curr Res Transl Med 2019 05 23;67(2):51-55. Epub 2019 Jan 23.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX, USA.

View Article and Find Full Text PDF

May 2019

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.

Authors:

Hossein Maymani Paul Lin Rima M Saliba Uday Popat Qaiser Bashir Nina Shah Krina Patel Simrit Parmar Partow Kebriaei Chitra Hosing Stefan Ciurea Borje Andersson Elizabeth Shpall Richard Champlin Samer A Srour Muzaffar H Qazilbash

Biol Blood Marrow Transplant 2019 05 11;25(5):1039-1044. Epub 2019 Jan 11.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

May 2019

Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.

Authors:

Neeraj Y Saini Romil D Patel Ankur Varma Qaiser Bashir Ruby Delgado Gabriela Rondon Uday Popat Chitra Hosing Yago Nieto Partow Kebriaei Donna M Weber Sheeba K Thomas Hans C Lee Elisabet E Manasanch Robert Z Orlowski Richard E Champlin Muzaffar H Qazilbash Krina K Patel

Am J Hematol 2019 03 21;94(3):E72-E74. Epub 2018 Dec 21.

Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

March 2019

Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma.

Authors:

Fatih M Uckun Sanjive Qazi Taner Demirer Richard E Champlin

EBioMedicine 2019 Jan 10;39:612-620. Epub 2018 Dec 10.

Department of Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article and Find Full Text PDF

January 2019

Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.

Authors:

Gheath Alatrash Kelly M Kidwell Peter F Thall Antonio Di Stasi Julianne Chen Madhushree Zope Alyssa K Crain Richard E Champlin Uday Popat Elizabeth J Shpall Roy B Jones Borje S Andersson

Bone Marrow Transplant 2019 08 10;54(8):1245-1253. Epub 2018 Dec 10.

The Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

August 2019

Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:

Ajay Sheshadri Roy F Chemaly Amin M Alousi Pankil K Shah Gabriela Rondon Lara Bashoura Joumana Kmeid Jacques Azzi David W Blanco Maryam Kaous Burton F Dickey Richard E Champlin Dimpy P Shah

Biol Blood Marrow Transplant 2019 04 3;25(4):800-809. Epub 2018 Dec 3.

Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

April 2019

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.

Oncotarget 2018 Nov 2;9(86):35611-35622. Epub 2018 Nov 2.

Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

November 2018

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.

Authors:

Lohith Gowda Mithun Shah Ifra Badar Qaiser Bashir Nina Shah Krina Patel Rashmi Kanagal-Shamanna Rohtesh Mehta Donna M Weber Hans C Lee Elisabet E Manasanch Abdul Shah Sheeba K Thomas Simrit Parmar Yago Nieto Robert Z Orlowski Richard Champlin Muzaffar H Qazilbash

Bone Marrow Transplant 2019 07 16;54(7):1089-1093. Epub 2018 Nov 16.

Department of Stem Cell Transplant, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

July 2019

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation.

Front Immunol 2018 23;9:2444. Epub 2018 Oct 23.

Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, United States.

View Article and Find Full Text PDF

September 2019

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial.

Lancet Haematol 2018 Nov;5(11):e532-e542

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

November 2018

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.

Authors:

Mithun Vinod Shah Rima M Saliba Gabriela Rondon Julianne Chen Doris Soebbing Ioana Rus Amin Alousi Betul Oran Partow Kebriaei Muzaffar Qazilbash Simrit Parmar Chitra Hosing Issa F Khouri Uday R Popat Richard E Champlin Stefan O Ciurea

Bone Marrow Transplant 2019 04 18;54(4):601-606. Epub 2018 Oct 18.

Department of Stem Cell Transplantation and Cellular Therapy, the University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

April 2019

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

Authors:

Lauren Veltri Katayoun Rezvani Betul Oran Rohtesh Mehta Gabriela Rondon Partow Kebriaei Uday Popat Yago Nieto Chitra Hosing Muzaffar Qazilbash Issa Khouri Elizabeth Shpall Richard Champlin David Marin

Biol Blood Marrow Transplant 2019 03 9;25(3):505-514. Epub 2018 Oct 9.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

March 2019

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.

Authors:

Muharrem Muftuoglu Amanda Olson David Marin Sairah Ahmed Victor Mulanovich Sudhakar Tummala T Linda Chi Alessandra Ferrajoli Indreshpal Kaur Li Li Richard Champlin Elizabeth J Shpall Katayoun Rezvani

N Engl J Med 2018 10;379(15):1443-1451

From the Departments of Stem Cell Transplantation and Cellular Therapy (M.M., A.O., D.M., S.A., I.K., L.L., R.C., E.J.S., K.R.), Infectious Diseases (V.M.), Neuro-Oncology (S.T.), Diagnostic Radiology (T.L.C.), and Leukemia (A.F.), M.D. Anderson Cancer Center, Houston.

View Article and Find Full Text PDF

October 2018

Melphalan-based autologous transplant in octogenarian multiple myeloma patients.

Am J Hematol 2019 01 31;94(1):E2-E5. Epub 2018 Oct 31.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

January 2019

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome.

Authors:

Piyanuch Kongtim Simrit Parmar Denái R Milton Jorge Miguel Ramos Perez Gabriela Rondon Julianne Chen Abhishek R Chilkulwar Gheath Al-Atrash Amin Alousi Borje S Andersson Jin S Im Chitra M Hosing Qaiser Bashir Issa Khouri Partow Kebriaei Betul Oran Uday Popat Richard Champlin Stefan O Ciurea

Bone Marrow Transplant 2019 06 26;54(6):839-848. Epub 2018 Sep 26.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

June 2019

Overall survival in older patients with cancer.

Authors:

Beatrice J Edwards Xiaotao Zhang Ming Sun Juhee Song Peter Khalil Meghan Sri Karuturi Linda Pang Yunlong Geng Colin P Dinney Vicente Valero Richard E Champlin Debasish Tripathy

BMJ Support Palliat Care 2020 Mar 22;10(1):25-35. Epub 2018 Sep 22.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF

March 2020

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Blood Adv 2018 09;2(17):2254-2261

Department of Stem Cell Transplantation and Cellular Therapy.

View Article and Find Full Text PDF

September 2018

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.

Br J Haematol 2018 11 2;183(4):578-587. Epub 2018 Sep 2.

Department of Lymphoma and Myeloma, the University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

November 2018

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.

Authors:

Benigno C Valdez Xiaowen Tang Yang Li David Murray Yan Liu Uday Popat Richard E Champlin Borje S Andersson

Exp Hematol 2018 11 10;67:49-59.e1. Epub 2018 Aug 10.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

November 2018

High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes.

Authors:

Bei Hu Peter Thall Denái R Milton Koji Sasaki Qaiser Bashir Nina Shah Krina Patel Uday Popat Chitra Hosing Yago Nieto Pei Lin Ruby Delgado Jeffrey Jorgensen Elisabet Manasanch Donna Weber Sheeba Thomas Robert Z Orlowski Richard Champlin Muzaffar H Qazilbash

Leuk Lymphoma 2019 02 22;60(2):442-452. Epub 2018 Jul 22.

d Department of Stem Cell Transplantation , UT MD Anderson Cancer Center , Houston, TX, USA.

View Article and Find Full Text PDF

February 2019

Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation.

Authors:

Aimaz Afrough Rima M Saliba Amir Hamdi Medhavi Honhar Ankur Varma A Megan Cornelison Gabriela Rondon Simrit Parmar Nina D Shah Qaiser Bashir Chitra Hosing Uday Popat Donna M Weber Sheeba Thomas Robert Z Orlowski Richard E Champlin Muzaffar H Qazilbash

Biol Blood Marrow Transplant 2018 11 9;24(11):2197-2203. Epub 2018 Aug 9.

Department of stem cell transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

November 2018

Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.

Authors:

Haige Ye Aakash Desai Shengjian Huang Dayoung Jung Richard Champlin Dongfeng Zeng Fangfang Yan Krystle Nomie Jorge Romaguera Makhdum Ahmed Michael L Wang

J Exp Clin Cancer Res 2018 Jul 13;37(1):150. Epub 2018 Jul 13.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article and Find Full Text PDF

July 2018

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes.

Authors:

Marcos de Lima Betul Oran Richard E Champlin Esperanza B Papadopoulos Sergio A Giralt Bart L Scott Basem M William Joel Hetzer Eric Laille Becky Hubbell Barry S Skikne Charles Craddock

Biol Blood Marrow Transplant 2018 10 20;24(10):2017-2024. Epub 2018 Jun 20.

Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

View Article and Find Full Text PDF

October 2018

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with mutations.

Authors:

Stefan O Ciurea Abhishek Chilkulwar Rima M Saliba Julianne Chen Gabriela Rondon Keyur P Patel Haitham Khogeer Abdul R Shah Brion V Randolph Jorge M Ramos Perez Uday Popat Chitra M Hosing Qaiser Bashir Rohtesh Mehta Gheath Al-Atrash Jin Im Issa F Khouri Partow Kebriaei Richard E Champlin

Blood 2018 06 16;131(26):2989-2992. Epub 2018 May 16.

Department of Stem Cell Transplantation and Cellular Therapy and.

View Article and Find Full Text PDF

June 2018

Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation.

Authors:

Jeff K Davies Lisa L Brennan John R Wingard Christopher R Cogle Neena Kapoor Ami J Shah Bimalangshu R Dey Thomas R Spitzer Marcos de Lima Laurence J Cooper Peter F Thall Richard E Champlin Lee M Nadler Eva C Guinan

Clin Cancer Res 2018 09 16;24(17):4098-4109. Epub 2018 May 16.

Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF

September 2018

Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.

Cancer 2018 06 12;124(12):2534-2540. Epub 2018 Apr 12.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

June 2018

Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation.

Authors:

Xerxes Pundole William A Murphy Chidinma C Ebede Erfan Karim Srishti Manocha Data Don-Pedro Gabriela Rondon Cheuk Hong Leung Suyu Liu Xianglin L Du Richard E Champlin Huifang Lu

Arch Osteoporos 2018 Apr 4;13(1):38. Epub 2018 Apr 4.

Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

April 2018

Neurocognitive deficits in older patients with cancer.

Authors:

Beatrice J Edwards Xiaotao Zhang Ming Sun Holly M Holmes Leena Ketonen Nandita Guha Peter Khalil Juhee Song Shelli Kesler Jay B Shah Debasish Tripathy Vicente Valero Richard E Champlin

J Geriatr Oncol 2018 09 9;9(5):482-487. Epub 2018 Mar 9.

Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, United States.

View Article and Find Full Text PDF

September 2018

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2018 08 2;24(8):1602-1609. Epub 2018 Mar 2.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

August 2018

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.

Authors:

Stefan O Ciurea Myriam Labopin Gerard Socie Liisa Volin Jakob Passweg Patrice Chevallier Dietrich Beelen Noel Milpied Didier Blaise Jan J Cornelissen Nathalie Fegueux Emmanuelle Polge Piyanuch Kongtim Gabriela Rondon Jordi Esteve Mohamad Mohty Bipin N Savani Richard E Champlin Arnon Nagler

Cancer 2018 05 22;124(10):2134-2141. Epub 2018 Feb 22.

Acute Leukemia Working Party, European Society for Blood and Marrow Transplantation, Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy, Paris, France.

View Article and Find Full Text PDF

May 2018

Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.

Authors:

Ella J Ariza-Heredia Roy F Chemaly Lokesh R Shahani Ying Jang Richard E Champlin Victor E Mulanovich

Transpl Int 2018 06 13;31(6):639-648. Epub 2018 Mar 13.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

June 2018

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Authors:

Mithun Vinod Shah Jeffrey L Jorgensen Rima M Saliba Sa A Wang Amin M Alousi Borje S Andersson Qaiser Bashir Stefan O Ciurea Partow Kebriaei David Marin Keyur P Patel Uday R Popat Katy Rezvani Gabriela Rondon Elizabeth J Shpall Richard E Champlin Betül Oran

Biol Blood Marrow Transplant 2018 07 12;24(7):1514-1520. Epub 2018 Feb 12.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

July 2018

Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells.

Authors:

Benigno C Valdez Yang Li David Murray Yan Liu Yago Nieto Richard E Champlin Borje S Andersson

Oncotarget 2018 Jan 17;9(3):3908-3921. Epub 2017 Dec 17.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article and Find Full Text PDF

January 2018

Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma).

Authors:

Dongfeng Zeng Aakash Desai Fangfang Yan Tiejun Gong Haige Ye Makhdum Ahmed Krystle Nomie Jorge Romaguera Richard Champlin Shaoying Li Michael Wang

Am J Clin Oncol 2019 03;42(3):304-316

Departments of Lymphoma and Myeloma.

View Article and Find Full Text PDF

March 2019

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.

Blood 2018 03 31;131(11):1248-1257. Epub 2018 Jan 31.

Laboratory Medicine, Division of Pathology/Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF

March 2018

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease.

Authors:

Ahmad Khoder Abdullah Alsuliman Rafet Basar Catherine Sobieski Kayo Kondo Amin Majid Alousi Richard Szydlo Muharrem Muftuoglu Hila Shaim Jane F Apperley Elif Gokdemir Nichola Cooper Rohtesh S Mehta David Marin Richard Champlin Elizabeth Shpall Katayoun Rezvani

Front Immunol 2017 12;8:1937. Epub 2018 Jan 12.

Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article and Find Full Text PDF

January 2018

Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016.

Authors:

Monzr M Al Malki Richard Jones Qing Ma Dean Lee Yair Reisner Jeffrey S Miller Peter Lang Suradej Hongeng Parameswaran Hari Samuel Strober Jianhua Yu Richard Maziarz Domenico Mavilio Denis-Claude Roy Chiara Bonini Richard E Champlin Ephraim J Fuchs Stefan O Ciurea

Biol Blood Marrow Transplant 2018 05 12;24(5):895-908. Epub 2018 Jan 12.

The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF

May 2018

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34 Selected and Unmodified Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2018 05 8;24(5):1079-1087. Epub 2018 Jan 8.

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article and Find Full Text PDF

May 2018